Rigel Pharmaceuticals Inc (RIGL) — Free Cash Flow Generation Index
Rigel Pharmaceuticals Inc (RIGL) has a Free Cash Flow Generation Index of 1.00x as of March 2026. Free cash flow of $2.73 Million represents 1% of operating cash flow ($2.73 Million). Read RIGL current and long-term liabilities for a breakdown of total debt and financial obligations.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Rigel Pharmaceuticals Inc Free Cash Flow Generation Index (2010–2025)
Historical FCF Generation Index trend for Rigel Pharmaceuticals Inc across 4 annual periods. Explore RIGL capex reinvestment rate to see what proportion of operating cash flow is directed to capital expenditures.
Annual Free Cash Flow Generation for Rigel Pharmaceuticals Inc (2010–2025)
Year-by-year Free Cash Flow Generation Index for Rigel Pharmaceuticals Inc. For the full company profile including market capitalisation, see market value of Rigel Pharmaceuticals Inc.
| Year | FCG Index | Free Cash Flow (USD) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2025 | 1.00x | $75.66 Million | $75.66 Million | $0.00 | ▲ +1.3% |
| 2024 | 0.99x | $31.07 Million | $31.47 Million | $396.00K | ▲ +10.5% |
| 2021 | 0.89x | $5.25 Million | $5.88 Million | $627.00K | ▼ -3.3% |
| 2010 | 0.92x | $43.18 Million | $46.74 Million | $3.56 Million | — |